). Hypoxic cells have been identified in both animal and human tumours and may limit tumour response to radiotherapy as hypoxia can protect cells from sparsely ionizing radiation (Bush et al. 1978 : Dische et al. 1983 : Bush. 1984 ). FurtherTnore. the success of various other treatment modalities [e.g. oxygen-dependent chemotherapeutic agents. cytokines such as tumour necrosis factor alpha (TNF-a) and interleukin 2 (IL-2). and photodynamic therapy] may also be influenced by tissue hypoxia (Freitas et al. 1991 : Chaplin et al. 1997: Vaupel. 1997. Evidence is also accumulating that suggests hypoxia may also be responsible for the development of an aggressive phenotype of tumour cells (Graeber et al. 1996 : Hoeckel et al. 1996a . 1996b ). Indeed. tumour oxygenation has been identified as a significant and independent oncological parameter for prediction of patient survival and local recurrence (Hoeckel et al. 1993 . 1996b : Nordsmark et al. 1996 and for the likelihood of distant metastases (Brizel et al. 1996) . Thus. in order to address the problem of hypoxia. many studies undertaken have been aimed at improving tumour oxygenation using a wide range of measures. although in many cases the success has been only limited (for reviews see Hirst. 1986 : Freitas et al. 1991 : Horsman. 1993 The possibility of modulating oxygen tensions in tumours through the use of hypothermia has been postulated previously.
The therapeutic effectiveness of several anti-cancer treatments may be compromised by the occurrence of microenvironmental abnormalities in tumour tissue. such as low pO, and pH levels and necrosis (Vaupel et al. 1989 : Vaupel. 1993 ). Hypoxic cells have been identified in both animal and human tumours and may limit tumour response to radiotherapy as hypoxia can protect cells from sparsely ionizing radiation (Bush et al. 1978 : Dische et al. 1983 : Bush. 1984 ). FurtherTnore. the success of various other treatment modalities [e.g. oxygen-dependent chemotherapeutic agents. cytokines such as tumour necrosis factor alpha (TNF-a) and interleukin 2 (IL-2). and photodynamic therapy] may also be influenced by tissue hypoxia (Freitas et al. 1991 : Chaplin et al. 1997 : Vaupel. 1997 . Evidence is also accumulating that suggests hypoxia may also be responsible for the development of an aggressive phenotype of tumour cells (Graeber et al. 1996 : Hoeckel et al. 1996a . 1996b ). Indeed. tumour oxygenation has been identified as a significant and independent oncological parameter for prediction of patient survival and local recurrence (Hoeckel et al. 1993 . 1996b : Nordsmark et al. 1996 and for the likelihood of distant metastases (Brizel et al. 1996) . Thus. in order to address the problem of hypoxia. many studies undertaken have been aimed at improving tumour oxygenation using a wide range of measures. although in many cases the success has been only limited (for reviews see Hirst. 1986 : Freitas et al. 1991 : Horsman. 1993 ).
The possibility of modulating oxygen tensions in tumours through the use of hypothermia has been postulated previously.
Studies usinr whole-body hypothermia in mice showed an increase in radiation response upon whole-body hypothermia.
which was purported to be due to an improvement in tumour oxygenation and a reduction in the hypoxic fraction resulting from a reduced oxygen consumption (Nias et al. 1986 (Nias et al. . 1988 pH and haematocrit) were detennined before and during treatment as described in detail previously (Kelleher et al. 1996) . This monitonng showed that all animals were in good physiological condition throughout the observation penrod. After pooling of tumour pO, data for each treatment group. frequency distributions of pO, values were constructed as shown in Figure 1 . The corresponding data for mean and median pO,. LPR and the fraction of p0, measurements between 0 and 2.5 mmHg are shown in Figure 2 RBC flux was 97 ± 6% (n = 9). 67 ± 4% (n = 9) and 37 ± 8% (n = 6) for the normothermia. 25°C and I5°C hypothermia groups respectively. These reductions were found to be statistically signif-35:C icant when the normothermia and hypothermia groups were compared (25°C, P < 0.001; 15°C. P < 0.01) and also when the two hypothermia groups were compared (P < 0.01). Because RBC flux was measured at various sites within individual tumours. the coefficient of variation could be calculated as a measure of inter-25.9C site variability. At the end of the normothermia or hypothermia treatment period, the coefficients of variation for the normothermia. 25°C and 15°C hypothermia groups were 23%. 31% and (1986, 1988) determined the effect of whole-body hypothermia (induced by anaesthesia) on blood flow, oxygen tension, oxygen consumption and tumour regrowth delay after tumour irradiation. They concluded that the increase in radiation response found upon whole-body hypothermia was due to an improvement in tumour oxygenation and a reduction in the hypoxic fraction, resulting from a reduced oxygen consumption occurring without change in the tumour blood supply as measured using the '33Xe clearance technique. In contrast to these findings, this study using localized hypoermia showed significant decreases in umour blood flow.
Nevertheless, an improvement in tunour oxygenation was still seen. If the direct effects of temperaue that could potentially influence umour oxygenation are considered, a complex picture is obtained which shows that prediction of changes in tumour oxygenation upon hypohermia may be difficult These direct effects include:
(a) Decreased oxygen consumption. In in vitro experiments with DS sarcoma cells the oxygen consumption rate at 37°C was approximately 0.03 ml g-min-', whereas at 250C and 150C it was 0.01 ml g-' min-' and 0.004 ml g-' min-' respectively (Vaupel and Kainowski, 1987) . The decreased oxygen consumption rate is paralleled by a hypothermia-induced slowing down of glycolysis, which in turn is mirrored by the reported slight increase in tumour tissue glucose concentration (Table 1) .
(b) Increased vascular resistance. While a temperature reduction in normal tissue leads to a prominent vasoconstriction, the situation in tumours may be somewhat different as newly formed blood vessels may lack smooth muscle in the vessel walls and thus not have the ability to vasoconstrict (Peterson, 1979; Konerding, 1989) . However, normal host vessels incorporated into the tumour or feeding the tumour may also play a significant role in the blood supply to tumour tissue. As these vessels still possess normal, temperature-sensitive vasocontractile properties, a vasoconstriction in response to hypothermia is presumably also at least partially responsible for the decrease in RBC flux seen in this study and also for the reduction in the 10-90% interpercentile range of the oxygenation measurements. by Grote et al, 1977) .
(e) A left shift of the oxygen dissociation curve (Reeves, 1980 (1977) ]. Of these direct effects of temperature on factors affecting tumour oxygenation, the oxygen dissociation curve shift, increased blood viscosity, increased peripheral resistance and the decrease in oxygen diffusivity would all tend to result in a worsening of tumour oxygenation, whereas the increased oxygen solubility and decreased oxygen consumption would contribute to an improvement in the tumour oxygenation.
When the improvement in tumour oxygenation (seen here as a reduction in the fraction of pO, measurements between 0 and 2.5 mmHg) in this study is considered, it becomes clear that changes occurring upon hypothermia, which would tend to lower tumour oxygenation, are more than outweighed by those changes occurring that would tend to lead to an improvement in tumour oxygenation. As the effect of the increase in oxygen solubility is only minimal, the decrease in oxygen consumption must be predominantly responsible for the improvement in tumour oxygenation seen. Efforts to overcome the vasoconstrictive effects of hypothermia (e.g. by a vasodilation of tumour or tumour-feeding vessels), or to decrease blood viscosity (e.g. using a methylxanthine derivative such as pentoxifylline), may prove to be useful in further enhancing possible radiosensitizing effects of hypothermia.
If the available litrature in which attempts have been made to improve tumour oxygenation is considered, it is clear that much effort has been focused on possibilities of increasing oxygen supply to tunour tissue. However, since tumour oxygenation is dependent on the balance between oxygen supply and consumption rate, both of dtese factors can be considered as targets of stategies to reduce tmour hypoxia. A theoretical sudy by Secomb et al (1995) analysed the effects of oxygen supply and demand on the hypoxic fraton in umours. They rported that tumour hypoxia could be abolished by a reduction in consumption me of at least 30%, by an increase in flow rate by a factor of 4 or more, or by an increase in arterial p0, by a factor of 11 or more. Such prnounced increases in blood flow or arterialpO, may be difficult to achieve, and Secomb et al's study concluded that it may be worthwhile considering possible methods to reduce oxygen consumption. This study has, therefore, investigated one method in which an improvement in tumour oxygenation could be achieved pfimarily through changes in oxygen consumption. Pharmacological intervention in cellular metabolic and/or biosyndtetic pathways requiring oxygen (e.g. with drugs such as lovastatin or Ca+ channel blockers) may also prove to be a possibility for altering tumour oxygenation (Thews et al, 1996) .
